Abstract
[This retracts the article DOI: 10.3389/fgene.2021.616220.].
Highlights
Specialty section: This article was submitted to RNA, a section of the journal Frontiers in Genetics
Concerns were raised regarding the validity of the data in the article
The lack of raw data, the editors no longer have confidence in the findings presented in the article
Summary
Specialty section: This article was submitted to RNA, a section of the journal Frontiers in Genetics. Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer Received: 24 January 2022 Accepted: 24 January 2022 Published: 31 January 2022
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
